Dheeraj Aggarwal, CFO, Venus Remedies is especially ecstatic about bagging the marketing rights for Meropenem in Gulf, Saudi Arabia as the company would be the first generic player there.

Venus Remedies signs out-licensing pact; stock up 20%

Venus Remedies entered OTC (over-the-counter) category with Ezenus. Dheeraj Aggarwal, CFO, Venus Remedies says that Ezenus is our first OTC product which is a stress reliever. It works for reducing anti-toxicants in the body.

New OTC drug to garner Rs 25cr revenues: Venus Remedies

Dheeraj Aggarwal, CFO, Venus Remedies, speaking to CNBC-TV18 on the occasion of the company's first ever over-the-counter (OTC) stress reliving drug launch, said that it is a unique product with no competition.